SCHEMBL6749907

SCHEMBL6749907

O=C(NN=Cc1cc(O)c(O)cc1O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.78
KMT2A Q03164 5/20 0.78
LMNA P02545 3/20 0.78
HTT P42858 3/20 0.78
SMN1; SMN2 Q16637 3/20 0.78
POLB P06746 3/20 0.78
PTBP1 P26599 2/20 0.78
TDP1 Q9NUW8 1/20 0.78
MAPT P10636 8/20 0.68
MEN1 O00255 3/20 0.64
HPGD P15428 4/20 0.62
HSP90AA1 P07900 1/20 0.62
GAA P10253 1/20 0.62
ALOX12 P18054 1/20 0.62
PHGDH O43175 1/20 0.53
ECE2 P0DPD6 1/20 0.52
ECE1 P42892 1/20 0.52
MUS81 Q96NY9 1/20 0.52
NPSR1 Q6W5P4 3/20 0.52
ALDH1A1 P00352 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6749902 1.00 KDM4E (0.78) KDM4EKMT2ALMNAHTTSMN1; SMN2
SCHEMBL6568354 0.88 KMT2A (0.78) KDM4EKMT2ALMNAHTTSMN1; SMN2
SCHEMBL6568357 0.88 KMT2A (0.78) KDM4EKMT2ALMNAHTTSMN1; SMN2
SCHEMBL6571437 0.88 KDM4E (0.78) KDM4EKMT2ALMNAHTTSMN1; SMN2
SCHEMBL6571440 0.88 KDM4E (0.78) KDM4EKMT2ALMNAHTTSMN1; SMN2
SCHEMBL6571710 0.88 KMT2A (1.00) KDM4EKMT2ALMNAHTTSMN1; SMN2
SCHEMBL6571712 0.88 KMT2A (1.00) KDM4EKMT2ALMNAHTTSMN1; SMN2
SCHEMBL684556 0.88 KMT2A (1.00) KDM4EKMT2ALMNAHTTSMN1; SMN2
SCHEMBL20587604 0.86 KMT2A (0.75) KDM4EKMT2ALMNAHTTSMN1; SMN2
SCHEMBL6569011 0.86 KMT2A (0.75) KDM4EKMT2ALMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110963-A1 Novel hydrazones ARPIDA AG (CH) 2004-06-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110963-A1 Novel hydrazones H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HK1, MPO KDM4E 3228/4885KMT2A 3368/4885LMNA 4156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.